RAPT Therapeutics, Inc. (RAPT)

NASDAQ: RAPT · IEX Real-Time Price · USD

2.790

-0.090 (-3.12%)

At close: Jul 2, 2024, 4:00 PM

2.860

+0.070 (2.51%)

After-hours: Jul 2, 2024, 4:39 PM EDT

RAPT Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2017
Revenue	0	1.53	3.81	5.04	0	Upgrade
Revenue Growth (YoY)	-	-59.95%	-24.38%	-	-	Upgrade
Gross Profit	0	1.53	3.81	5.04	0	Upgrade
Selling, General & Admin	26.06	20.24	16.04	12.77	8.72	Upgrade
Research & Development	101	67.08	56.99	45.49	34.91	Upgrade
Operating Expenses	127.06	87.32	73.02	58.26	43.63	Upgrade
Operating Income	-127.06	-85.8	-69.21	-53.21	-43.63	Upgrade
Other Expense / Income	-10.26	-1.96	-0.01	-1.31	-1.29	Upgrade
Pretax Income	-116.8	-83.84	-69.2	-51.9	-42.34	Upgrade
Income Tax	0	0	0	0.99	0.66	Upgrade
Net Income	-116.8	-83.84	-69.2	-52.89	-43	Upgrade
Shares Outstanding (Basic)	38	33	27	24	4	Upgrade
Shares Outstanding (Diluted)	38	33	27	24	4	Upgrade
Shares Change	17.82%	18.80%	13.49%	455.27%	598.45%	Upgrade
EPS (Basic)	-3.05	-2.58	-2.53	-2.19	-9.89	Upgrade
EPS (Diluted)	-3.05	-2.58	-2.53	-2.19	-9.89	Upgrade
Free Cash Flow	-98.17	-71.62	-61.78	-40.89	-36.32	Upgrade
Free Cash Flow Per Share	-2.56	-2.20	-2.26	-1.69	-8.36	Upgrade
Gross Margin	-	100.00%	100.00%	100.00%	-	Upgrade
Operating Margin	-	-5618.53%	-1815.08%	-1055.41%	-	Upgrade
Profit Margin	-	-5490.37%	-1814.95%	-1049.03%	-	Upgrade
Free Cash Flow Margin	-	-4689.98%	-1620.27%	-810.97%	-	Upgrade
EBITDA	-113.25	-81.03	-68.21	-50.78	-41.01	Upgrade
EBITDA Margin	-	-5306.55%	-1788.83%	-1007.12%	-	Upgrade
Depreciation & Amortization	3.55	2.81	1	1.12	1.33	Upgrade
EBIT	-116.8	-83.84	-69.2	-51.9	-42.34	Upgrade
EBIT Margin	-	-5490.37%	-1814.95%	-1029.39%	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).